These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12424150)

  • 21. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Implantable cardioverter-defibrillator(ICD)].
    Kurita T
    Nihon Rinsho; 2002 Jul; 60(7):1353-60. PubMed ID: 12136614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical issues with implantable defibrillators.
    Brennan FJ
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
    [No Abstract]   [Full Text] [Related]  

  • 25. Ethical issues with implantable defibrillators.
    Veenhuyzen GD; Simpson CS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
    [No Abstract]   [Full Text] [Related]  

  • 26. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comments on ethical issues with implantable defibrillators by F. James Brennan.
    Rahmoeller G
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):899. PubMed ID: 15271006
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-arrhythmic effects of statins: a hypothesis remains to be tested.
    Guo HM
    Heart Rhythm; 2008 Apr; 5(4):511-2. PubMed ID: 18362017
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.
    Weeks PA; Sieg A; Gass JA; Rajapreyar I
    Heart Fail Rev; 2016 Jul; 21(4):415-31. PubMed ID: 27003591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 33. Does the arrhythmic risk of patients with ischaemic cardiomyopathy really benefit from revascularisation therapy?
    Kallergis EM; Mavrakis HE; Vardas PE
    Hellenic J Cardiol; 2008; 49(4):203-6. PubMed ID: 18935706
    [No Abstract]   [Full Text] [Related]  

  • 34. Secondary prevention of sudden death.
    Cappato R; Kuck KH
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():39-44. PubMed ID: 10590487
    [No Abstract]   [Full Text] [Related]  

  • 35. How implantable cardioverter-defibrillators work and simple programming.
    Bryant RM
    Cardiol Young; 2017 Jan; 27(S1):S121-S125. PubMed ID: 28084970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indications for an implantable cardioverter/defibrillator].
    Schwab JO; Lüderitz B
    Internist (Berl); 2007 Jul; 48(7):715-23; quiz 724-5. PubMed ID: 17541533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation of Tp-e interval and Tp-e/Q-T ratio with malignant ventricular arrhythmia in patients with implantable cardioverter-defibrillator for primary prevention].
    Zhu TY; Teng SE; Chen YY; Liu SR; Meng SR; Peng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):401-4. PubMed ID: 27063171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anxiety and anxiety management in patients with implanted cardioverter-defibrillators].
    Ladwig KH; Wirsching C; V Hammerstein A; Danner R; Baumert J; Schmitt C
    Dtsch Med Wochenschr; 2004 Oct; 129(43):2311-5. PubMed ID: 15483771
    [No Abstract]   [Full Text] [Related]  

  • 40. The marriage of true minds: the partner of the ICD patient as a new focus for study.
    Newman D; Crystal E
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1427-9. PubMed ID: 20946277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.